We demonstrated a significant upregulation of DDR1 and a downregulation of DDR2 in lung tumour tissue compared with matched normal tissues from the same patients; importantly we demonstrated that DDR1 expression was a good prognostic marker for early-stage NSCLC patients. The gene discussed is DDR1; the disease is non-small cell lung carcinoma.